SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-094109
Filing Date
2024-08-08
Accepted
2024-08-08 16:36:43
Documents
53
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xene-20240630.htm   iXBRL 10-Q 1897758
2 EX-31.1 xene-ex31_1.htm EX-31.1 15243
3 EX-31.2 xene-ex31_2.htm EX-31.2 15217
4 EX-32.1 xene-ex32_1.htm EX-32.1 10809
5 EX-32.2 xene-ex32_2.htm EX-32.2 10264
  Complete submission text file 0000950170-24-094109.txt   6157497

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT xene-20240630.xsd EX-101.SCH 764198
56 EXTRACTED XBRL INSTANCE DOCUMENT xene-20240630_htm.xml XML 945009
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 241189091
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)